Registry · VX-RETA-20
Triple R 20mg
An analysis report has been published for this reference. What it covers is below — and what it leaves out is listed just as plainly.
Reference
VX-RETA-20
Laboratory
Janoshik Analytical
Report #195362. Accreditation not stated on the report.
Batch tested
VP02062026-RT20
Test requested
Common GLP-1 peptide blind test (Semaglutide, Tirzepatide and Retatrutide)
Retatrutide
21.93 mg
Purity
99.948 %
Dates
sample received 2026-06-24 · analysed 2026-06-30
The manufacturing date is not stated on the report, so the batch cannot be placed in
time relative to the test.
Who commissioned it
Vela Peptides — the party that manufactures the material
The sample was supplied and paid for by the party being tested. That is the ordinary
arrangement and it is not disqualifying — but the sample was chosen by an interested
party. Why that matters.
Graph
not published The only attachment is a photograph of the vial.
Not covered
water content · counterion · endotoxin · sterility · manufacturing date
None of these were requested, so the report says nothing about them. That is not a
finding against the material — it is the scope of what was ordered.
Read the report at the laboratory What each line means
Every figure above is transcribed from the laboratory’s own published page, linked beside it. This registry does not restate results it has not read, and does not fill in fields the report leaves empty.
Look up another reference
Every VERAX reference has a page here, whether or not a report has been published for it.
REPORT REGISTRY · v2.0
$ awaiting lot identifier...
Three EXAMPLE- records demonstrate a complete, an incomplete and a self-contradicting report. Alongside them sit the products VERAX Research sells, by reference, showing which have a published report and which do not.